People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Technology, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanosys, Inc. | — | Other Technology | Series B | $96.9M | $296.3M | 2010 |
| Alcyone Lifesciences, Inc. | — | Other Health Care | Series B | $93.2M | $151.6M | 2018 |
| MicroCHIPS, Inc. | — | Biotechnology | Series B | $27.9M | $740.1M | 2009 |
Stephen Oesterle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Oesterle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Michael Greeley | 1 | 15 |
| Robert S Langer | 1 | 14 |
| Keith Crandell | 1 | 11 |
| Terrance McGuire | 1 | 9 |
| TERRANCE G. MCGUIRE | 1 | 7 |
| Robert Crane | 1 | 7 |
| John Young | 1 | 7 |
| Nelson Chan | 1 | 7 |
| Richard Upton | 1 | 6 |
| Edgar D. Jannotta, Jr. | 1 | 6 |
| Cameron Durrant | 1 | 5 |
| John Santini | 1 | 5 |
| David Donabedian | 1 | 4 |
| Cheryl R. Blanchard | 1 | 4 |
| PJ Anand | 1 | 4 |
| Steven Goldby | 1 | 3 |
| Stephen D Oesterle | 1 | 3 |
| Young Sohn | 1 | 3 |
| Bruce Berkoff | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.